Luis Algeciras Jiménez was given his degree on in Basic and Experimental Biomedicine from the University of Seville in 2016. That same year, after finishing his university degree, he was granted with a scholarship provided by the AECC (Spanish Association Against Cancer) to perform a research related to genetical immunomodulation in immune and cancer cells during the summer months at the Faculty of Pharmacy and Nutrition of the University of Barcelona. During the 2016-2017 academic year, he studied and obtained a Master's degree in Cognitive and Behavioural Neuroscience from the University of Granada.
From the beginning of 2018 until the end of 2019 he obtained a position of Laboratory Technician granted by the "Garantía Juvenil" spanish employment system in calls number 2 and 3, where he carried out two different contracts at the Institute of Biomedicine of Seville (IBiS). During his first contract he worked at the laboratory of JJ Toledo-Aral following the line of research "Cellular Therapies in Parkinson's Disease" while in the second he developed and started a new line of research amongst J. Ureña and L. Varela which consisted in using High Density Lipoproteins (HDL) and its subclasses both as a biological marker and possible treatment for subarachnoid hemorrhage caused by aneurysmal rupture.
Today he is at his first year of doctorate (PhD) in Biomedicine under the advisement of A.V Villar on the in vivo study of molecular design therapies and a genetically modified nanotransporter as a specific system against cardiac fibrosis.
Host group to: Dra. Matxalen LLosa
Link to our Blog to keep you informed of our latest news: http://villarav.blogspot.com.es
Link to our webpage at the University of Cantabria http://web.unican.es/ibbtec/Paginas/Groups/Villar.aspx
Lab Retreat 2019
Instituto de Biomedicina y Biotecnología de Cantabria.
PCTCAN - Cl. Albert Einstein, 22